- Home
- Publications
- Publication Search
- Publication Details
Title
What Is Recent in Pancreatic Cancer Immunotherapy?
Authors
Keywords
-
Journal
Biomed Research International
Volume 2013, Issue -, Pages 1-14
Publisher
Hindawi Limited
Online
2012-12-27
DOI
10.1155/2013/492372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the assessment and control of the effector functions of therapeutic antibodies
- (2011) Xu-Rong Jiang et al. NATURE REVIEWS DRUG DISCOVERY
- Targeting Mutated K-ras in Pancreatic Adenocarcinoma Using an Adjuvant Vaccine
- (2010) Ghassan K. Abou-Alfa et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Current strategies to target p53 in cancer
- (2010) Fang Chen et al. BIOCHEMICAL PHARMACOLOGY
- Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
- (2010) L. M. Weiner et al. Cancer Prevention Research
- Increased Immunogenicity of Tumor-Associated Antigen, Mucin 1, Engineered to Express -Gal Epitopes: A Novel Approach to Immunotherapy in Pancreatic Cancer
- (2010) T. Deguchi et al. CANCER RESEARCH
- DNA Vaccination: Using the Patient's Immune System to Overcome Cancer
- (2010) Georg Eschenburg et al. Clinical & Developmental Immunology
- Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusions
- (2010) Shigeo Koido et al. CLINICAL IMMUNOLOGY
- MUC1 immunotherapy
- (2010) Richard E Beatson et al. Immunotherapy
- A novel high-affinity human monoclonal antibody to mesothelin
- (2010) Mitchell Ho et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term follow-up of patients with resected pancreatic cancer following vaccination against mutant K-ras
- (2010) Synne Wedén et al. INTERNATIONAL JOURNAL OF CANCER
- Gemcitabine Plus Bevacizumab Compared With Gemcitabine Plus Placebo in Patients With Advanced Pancreatic Cancer: Phase III Trial of the Cancer and Leukemia Group B (CALGB 80303)
- (2010) Hedy Lee Kindler et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205
- (2010) Philip A. Philip et al. JOURNAL OF CLINICAL ONCOLOGY
- Mass Spectrometry Analysis of the Post-Translational Modifications of α-Enolase from Pancreatic Ductal Adenocarcinoma Cells
- (2010) Weidong Zhou et al. JOURNAL OF PROTEOME RESEARCH
- Reactivity of a humanized antibody (hPankoMab) towards a tumor-related MUC1 epitope (TA-MUC1) with various human carcinomas
- (2010) Xiao-Na Fan et al. PATHOLOGY RESEARCH AND PRACTICE
- Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts
- (2009) C. Larbouret et al. ANNALS OF ONCOLOGY
- Induction of protective and therapeutic anti-pancreatic cancer immunity using a reconstructed MUC1 DNA vaccine
- (2009) Yefei Rong et al. BMC CANCER
- HER2 overexpression correlates with survival after curative resection of pancreatic cancer
- (2009) Masahiro Komoto et al. CANCER SCIENCE
- Phase I clinical trial using peptide vaccine for human vascular endothelial growth factor receptor 2 in combination with gemcitabine for patients with advanced pancreatic cancer
- (2009) Motoki Miyazawa et al. CANCER SCIENCE
- Survivin: A new target for anti-cancer therapy
- (2009) Bríd M. Ryan et al. CANCER TREATMENT REVIEWS
- Phase I Trial of Continuous Infusion Anti-Mesothelin Recombinant Immunotoxin SS1P
- (2009) R. J. Kreitman et al. CLINICAL CANCER RESEARCH
- Circulating Mesothelin Protein and Cellular Antimesothelin Immunity in Patients with Pancreatic Cancer
- (2009) F. Mc. Johnston et al. CLINICAL CANCER RESEARCH
- Peptide-Based Anticancer Vaccines: Recent Advances and Future Perspectives
- (2009) S. Mocellin et al. CURRENT MEDICINAL CHEMISTRY
- Synthetic Peptide-Based Cancer Vaccines: Lessons Learned and Hurdles to Overcome
- (2009) Caroline Voskens et al. CURRENT MOLECULAR MEDICINE
- Cancer immunotherapy by fusions of dendritic cells and tumor cells
- (2009) Shigeo Koido et al. Immunotherapy
- An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
- (2009) Paola Cappello et al. INTERNATIONAL JOURNAL OF CANCER
- Antitumor Efficacy of Trastuzumab in Nude Mice Orthotopically Xenografted With Human Pancreatic Tumor Cells Expressing Low Levels of HER-2/neu
- (2009) Graziella Pratesi et al. JOURNAL OF IMMUNOTHERAPY
- A novel human monoclonal antibody that binds with high affinity to mesothelin-expressing cells and kills them by antibody-dependent cell-mediated cytotoxicity
- (2009) Y. Feng et al. MOLECULAR CANCER THERAPEUTICS
- Immune infiltration in human tumors: a prognostic factor that should not be ignored
- (2009) F Pagès et al. ONCOGENE
- Enhancement of anti-tumor immunity by high levels of Th1 and Th17 with a combination of dendritic cell fusion hybrids and regulatory T cell depletion in pancreatic cancer
- (2009) Kamigaki ONCOLOGY REPORTS
- The αGal HyperAcute®Technology: Enhancing Immunogenicity of Antiviral Vaccines by Exploiting the Natural αGal-Mediated Zoonotic Blockade
- (2009) R. B. Mandell et al. Zoonoses and Public Health
- Structure of human α-enolase (hENO1), a multifunctional glycolytic enzyme
- (2008) Hyo Jin Kang et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients
- (2008) I. Hellstrom et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
- (2008) Antoun Toubaji et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- The Immunogenicity of the hTERT540-548 Peptide in Cancer
- (2008) L. Wenandy et al. CLINICAL CANCER RESEARCH
- Allogeneic Granulocyte Macrophage Colony-Stimulating Factor-Secreting Tumor Immunotherapy Alone or in Sequence with Cyclophosphamide for Metastatic Pancreatic Cancer: A Pilot Study of Safety, Feasibility, and Immune Activation
- (2008) D. Laheru et al. CLINICAL CANCER RESEARCH
- Targeted Therapies to Improve Tumor Immunotherapy
- (2008) J. Begley et al. CLINICAL CANCER RESEARCH
- Superior induction of anti-tumor CTL immunity by extended peptide vaccines involves prolonged, DC-focused antigen presentation
- (2008) Martijn S. Bijker et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Peptide-based vaccines for cancer: realizing their potential
- (2008) Shreya Kanodia et al. Expert Review of Vaccines
- Strategies used for MUC1 immunotherapy: human clinical studies
- (2008) Choon-Kit Tang et al. Expert Review of Vaccines
- Cell fusion: from hybridoma to dendritic cell-based vaccine
- (2008) Jianlin Gong et al. Expert Review of Vaccines
- Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer
- (2008) M. Li et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Immunology
- (2008) Olivera J. Finn NEW ENGLAND JOURNAL OF MEDICINE
- Releasable PEGylation of proteins with customized linkers
- (2007) David Filpula et al. ADVANCED DRUG DELIVERY REVIEWS
- The Galα1,3Galβ1,4GlcNAc-R (α-Gal) epitope: A carbohydrate of unique evolution and clinical relevance
- (2007) Bruce A. Macher et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started